Australian Pharmaceutical Industries Ltd
ASX:API
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Jinan Shengquan Group Share Holding Co Ltd
SSE:605589
|
CN |
|
U
|
Ugar Sugar Works Ltd
NSE:UGARSUGAR
|
IN |
|
China Foods Ltd
HKEX:506
|
HK |
|
R Stahl AG
XETRA:RSL2
|
DE |
|
Village Super Market Inc
NASDAQ:VLGEA
|
US |
|
Sichuan New Energy Power Co Ltd
SZSE:000155
|
CN |
|
Gray Television Inc
NYSE:GTN
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (1.7), the stock would be worth AU$1.53 (0% downside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 1.7 | AU$1.53 |
0%
|
| 3-Year Average | 1.7 | AU$1.53 |
0%
|
| 5-Year Average | 1.7 | AU$1.53 |
0%
|
| Industry Average | 3.3 | AU$2.9 |
+90%
|
| Country Average | 2.7 | AU$2.38 |
+56%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| AU |
|
Australian Pharmaceutical Industries Ltd
ASX:API
|
753.8m AUD | 1.7 | 547.4 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
105.7B USD | -80 | 23.9 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
62.9B USD | 33 | 38.7 | |
| US |
|
Cencora Inc
NYSE:COR
|
62.8B USD | 31.9 | 37.5 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
49.8B USD | -16.8 | 29.2 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
32B AUD | 6.6 | 35.8 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
62.8B CNY | 0.8 | 11 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9.2B USD | 2.8 | 23.2 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
60.4B CNY | 2.5 | 16.2 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 6 | 89.6 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
63.8B HKD | 0.7 | 7.9 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.6 |
| Median | 2.7 |
| 70th Percentile | 4.3 |
| Max | 2 199.4 |
Other Multiples
Australian Pharmaceutical Industries Ltd
Glance View
Australian Pharmaceutical Industries Ltd. engages in the wholesale, product delivery, retail services, marketing programs and business advisory services. The company is headquartered in Melbourne, Victoria. The Company’s segments include Australia and New Zealand. The Australia segment is engaged in distribution of pharmaceutical, medical, health, beauty and lifestyle products and retail services to pharmacies, the purchase and sale of health, beauty and lifestyle products and services within the retail industry, including cosmetic products and non-invasive procedures. The New Zealand segment manufactures and owns rights for pharmaceutical medicines and consumer toiletries. The firm's brands include Priceline & Priceline Pharmacy, which is a health, beauty and wellbeing retailer; Soul Pattinson Chemist, which is a pharmacy brand; Pharmacist Advice, which offers professional service and advice; Club Premium, which is a club for independent pharmacies, and Pharmacy Best Buys, which offers a catalog program.